Royal Bank Of Canada Danaher Corp Call Options Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$239.25 - $280.76 $789,525 - $926,508	-3,300 Reduced 6.19%	50,000 $13.9 Million
Q2 2024 Aug 14, 2024	BUY	$235.51 - $267.98 $11 Million - $12.5 Million	46,600 Added 695.52%	53,300 $13.3 Million
Q1 2024 Nov 05, 2024	SELL	$224.58 - $256.19 $10.5 Million - $11.9 Million	-46,600 Reduced 87.43%	6,700 $1.67 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $1.5 Million - $1.72 Million	6,700 New	6,700 $1.67 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $854,962 - $973,332	3,800 New	3,800 $912,000
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $3.21 Million - $19.6 Million	13,000 Added 45.61%	41,500 $10.7 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $2.89 Million - $3.66 Million	-12,200 Reduced 29.98%	28,500 $7.23 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $6.46 Million - $7.93 Million	25,100 Added 160.9%	40,700 $11.9 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $4.25 Million - $5.19 Million	15,600 New	15,600 $4.75 Million

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.